CABLIVI

CAPLACIZUMAB · Genzyme Corporation

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for CABLIVI, covering 2017-11-14 to 2026-04-09. Get the full timeline:

Most recent: EMA Authorised: Cablivi (Caplacizumab) — Ablynx NV